EarningsQ4 2021 Earnings Report

Pharma Mar SA (PHM1N) Q4 2021 Earnings Report

0 Followers

MX:PHM1N Q4 2021 EPS Results

Actual EPS$44.61

Consensus EPS―

Beat/Miss―

One Year Ago EPS$7.18

Actual Revenue$1.81B

Expected Revenue$505.36M

Beat/MissBeat by +$1.30B

YoY Revenue Growth+79.66%

QuarterQ4 2021

Date02/28/2022

TimeTBA

Conference CallMonday, February 28, 2022

MX:PHM1N Upcoming Earnings

Pharma Mar SA's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 01, 2027	2026 (Q4)	20.69 / -	70.208	―
Oct 29, 2026	2026 (Q3)	2.67 / 9.89	-2.737	461.54% (+12.63)
Jul 29, 2026	2026 (Q2)	3.75 / -1.26	27.894	-104.53% (-29.16)
Apr 23, 2026	2026 (Q1)	2.63 / 1.89	-2.316	181.82% (+4.21)
Feb 27, 2026	2025 (Q4)	64.63 / 70.21	21.999	219.14% (+48.21)
Oct 30, 2025	2025 (Q3)	-3.26 / -2.74	4.21	-165.00% (-6.95)
Jul 30, 2025	2025 (Q2)	0.63 / 27.89	1.368	1938.46% (+26.53)
Apr 24, 2025	2025 (Q1)	6.63 / -2.32	2.526	-191.67% (-4.84)
Feb 28, 2025	2024 (Q4)	20.42 / 22.00	-8	375.00% (+30.00)
Oct 29, 2024	2024 (Q3)	4.32 / 4.21	1.684	150.00% (+2.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed